FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/09/2026
Back to search
Official data from USPTO
ARAMIS BIOTECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/09/2026
Trademark type
Combined
Nice classes
5, 40, 42, 44
Filing date
09/05/2024
Registration date
12/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/02/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
CA
Examiner
FREEMAN, BREANNA SHALEISE
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "ARAMIS" with a leaf incorporated as part of the "i". Below is the stylized wording "BIOTECHNOLOGIES".
Holders and representatives
Holders
Biotechnologies Aramis inc.
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations and substancesvaccines; pharmaceutical and medicinal preparations and substancesrecombinant proteins in the nature of pharmaceutical preparations for the treatment and prevention of infectious diseases
Class 40
Custom manufacture of pharmaceuticalspharmaceutical ingredients and human vaccinescustom manufacturing of pharmaceuticalspharmaceutical ingredients and human vaccines.
Class 42
Research and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services in the field of recombinant protein platform technologies for new human vaccines; product research and development and scientific researchall in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticalspharmaceutical ingredients and human vaccines; medical and scientific research in the field of clinical trial studies on new vaccine candidates for others
Class 44
Medical information servicesproviding information to physicianshealthcare professionals and patients on the topics of health issues that can be treated with vaccinesdiagnosticprophylactic and therapeutic properties of vaccines; on-line health information servicesproviding information to physicianshealthcare professionals and patients on the topics of health issues that can be treated with vaccinesdiagnosticprophylactic and therapeutic properties of vaccines
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/18/2026
FIMP
FINAL DISPOSITION PROCESSED
06/18/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/20/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/14/2025
PUBO
PUBLISHED FOR OPPOSITION
10/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2025
RFNT
REFUSAL PROCESSED BY IB
05/04/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/15/2025
RFRR
REFUSAL PROCESSED BY MPU
04/15/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2025
CNRT
NON-FINAL ACTION WRITTEN
03/09/2025
DOCK
ASSIGNED TO EXAMINER
03/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/24/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2024
Continuous trademark protection
Get notified about every new filing that threatens ARAMIS BIOTECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.